Botulinum Toxins

BIODEFENSE: Research Methodology and Animal Models

Volumn , Issue , 2005, Pages 259-274

  Greenbaum, Stephen B ^a   Anderson, Jaime B ^b  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

^b National Biodefense Analysis and Countermeasures Center (NBACC)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857189998     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420038118-18     Document Type: Chapter

References (92)

1. Simpson, L., Identification of the major steps in botulinum toxin action, Ann. Rev. Pharmacol. Toxicol., 44, 167, 2004.
2. Schiavo, G. et al., Botulinum neurotoxins are zinc proteins, J. Biol. Chem., 267, 23479, 1992.
3. Schiavo, G. et al., Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E, J. Biol. Chem., 268, 23784, 1993.
4. Schiavo, G. et al., Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/Synaptobrevin, J. Biol. Chem. 268, 11516, 1993.
5. Blasi, J. et al., Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25, Nature, 365, 104, 1993.
6. Schiavo, G. et al., Botulinum G neurotoxin cleaves VAMP/Synaptobrevin at a single Ala-Ala peptide bond, J. Biol. Chem., 269, 20213, 1994.
7. Yamasaki, S. et al., Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin, J. Biol. Chem., 269, 12764, 1994.
8. Schiavo, G. et al., Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins, J. Biol. Chem., 270, 10566, 1995.
9. Simpson, L., The origin, structure, and pharmacological activity of botulinum toxin, Pharmacol. Rev., 33, 155, 1981.
10. Schiavo, G., Matteoli, M., and Montecucco, C., Neurotoxins affecting neurocytosis, Physiol. Rev., 80, 717, 2000.
11. Ohishi, I., Sugii, S., and Sakaguchi, G., Oral toxicities of Clostridium botulinum toxins in response to molecular size, Infection Immunity, 16, 107, 1977.
12. Sugii, S., Ohishi, I., and Sakaguchi, G., Oral toxicities of Clostridium botulinum toxins, Jpn. J. Med. Sci. Biol., 30, 70, 1977.
13. Sugii, S., Ohishi, I., and Sakaguchi, G., Correlation between oral toxicity and in vitro stability of clostridium botulinum type A and B toxins of different molecular sizes, Infection Immunity, 16, 910, 1977.
14. Sugii, S., Ohishi, I., and Sakaguchi, G., Intestinal absorption of botulinum toxins of different molecular sizes in rats, Infection Immunity, 17, 491, 1977.
15. Ohishi, I., Absorption of Clostridium botulinum type B toxins of different molecular sizes from different regions of rat intestine, FEMS Microbiol. Lett., 16, 257, 1983.
16. Fujinaga, Y. et al., The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of guinea pig small intestine, leading to the efficient absorption of the toxin, Microbiology, 143, 3841, 1997.
17. Daniels-Holgate, P. and Dolly, J., Productive and non-productive binding of botulinum neurotoxin A to motor nerve endings are distinguished by its heavy chain, J. Neurosci. Res., 44, 263, 1996.
18. Lalli, G. et al., Functional characterisation of tetanus and botulinum neurotoxins binding domains, J. Cell. Sci., 112, 2715, 1999.
19. Arnon, S. et al., Botulinum toxin as a biological weapon, J. Am. Med. Assoc., 285, 1059, 2001.
20. Cherington, M., Clinical spectrum of botulism, Muscle Nerve, 21, 701, 1998.
21. Middlebrook, J. and Franz, D., Botulinum Toxins, in Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare, Office of the Surgeon General, Department of the Army, 1997.
22. Mackle, I., Halcomb, E., and Parr, M., Severe adult botulism, Anaesth. Intensive Care, 29, 297, 2001.
23. Maselli, R., Pathogenesis of human botulism, Ann. N.Y. Acad. Sci. 841, 122, 1998.
24. Sonnabend, O. et al., Isolation of Clostridium botulinum type G and identification of type G botulinal toxin in humans: Report of 5 sudden unexpected deaths, J. Infect. Dis., 143, 22, 1981.
25. Lamanna, C., The most poisonous poison, Science, 130, 763, 1959.
26. Lecour, H. et al., Food-borne botulism: a review of 13 outbreaks, Arch. Intern. Med., 148, 578, 1988.
27. Bulatova, Z. and Kaulen, D., Natural resistance of irradiated animals to botulin toxins, J. Hyg., Epidemiol., Microbiol., and Immunol., 10, 67, 1966.
28. Sakaguchi, G. and Sakaguchi, S., Oral toxicities of Clostridium botulinum type E toxins of different forms, Jpn. J. Med. Sci. Biol. 27, 241, 1974.
29. Sugiyama, H., DasGupta, B., and Yang, K., Toxicity of purified botulinal toxin fed to mice, Proc. Soc. Exp. Biol. Med., 147, 589, 1974.
30. Ohishi, I., Oral toxicities of Clostridium botulinum type A and B toxins from different strains, Infection Immunity, 43, 487, 1984.
31. Nukina, M. et al., Detection of neutral sugars in purified type G botulinum progenitor toxin and the effects of some glycolytic enzymes on its molecular dissociation and oral toxicity, FEMS Microbiol. Lett., 79, 159, 1991.
32. Ohishi, I., Sugii, S., and Sakaguchi, G., Absorption of botulinum type B progenitor and derivative toxins through the intestine, Jpn. J. Med. Sci. Biol., 31, 161, 1978.
33. Miyazaki, S. and Sakaguchi, G., Experimental botulism in chickens: the cecum as the site of production and absorption of botulinum toxin, Jpn. J. Med. Sci. Biol., 31, 1, 1978.
34. Zacks, S. and Sheff, M., Biochemistry and mechanism of action of toxic proteins, U.S. Army Edgewood Arsenal, Final Progress Report, DTIC AD816140, 1969.
35. Williams, R. et al., Radioiodination of botulinum neurotoxin type A with retention of biological activity and its binding to brain synaptosomes, Eur. J. Biochem., 131, 437, 1983.
36. Agui, T. et al., Binding of Clostridium botulinum type C neurotoxin to rat brain synapses, J. Biochem., 94, 521, 1983.
37. Evans, D. et al., Botulinum neurotoxin type B: Its purification, radioiodination and interaction with rat-brain synaptosomal membranes, Eur. J. Biochem., 154, 409, 1986.
38. Yokosawa, N. et al., Binding of Clostridium botulinum type C neurotoxin to different neuroblastoma cell lines, Infection and Immunity, 57, 272, 1989.
39. Bakry, N., Kamata, Y., and Simpson, L., Expression of botulinum toxin binding sites in Xenopus oocytes, Infection and Immunity, 65, 2225, 1997.
40. Hirokawa, N. and Kitamura, M., Binding of Clostridium neurotoxin to the presynaptic membrane in the central nervous system, J. Cell. Biol., 81, 43, 1979.
41. Black, J. and Dolly, J., Selective location of acceptors for botulinum neurotoxin A in the central and peripheral nervous systems, Neurosci., 23, 767, 1987.
42. Herreros, J. et al., Localization of putative receptors for tetanus toxin and botulinum neurotoxin type A in rat central nervous system, Eur. J. Neurosci., 9, 2677, 1997.
43. Foran, P. et al., Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A, J. Biol. Chem., 278, 1363, 2003.
44. Sergeyeva, T., Detection of botulinal toxin and type A microbe in the organism of sick animals and in the organs of cadavers, Zhurnal Mikrobiologii, 33, 96, 1962.
45. Cardella, M. et al., Resistance of guinea pigs immunized with botulinum toxoids to aerogenic challenge with toxin, U.S. Army Biological Laboratories Report, Test No. 60-TE-1323, DTIC AD0404870, 1963.
46. Sergeyeva, T., Detection of type E botulin toxin in an organism, Zhurnal Mikrobiologii, 4, 54, 1966.
47. Moll, T. and Brandly, C., Botulism in the mouse, mink, and ferret with special reference to susceptibility and pathological alterations, Am. J. Vet. Res., 12, 355, 1951.
48. May, A. and Whaler, B., The absorption of Clostridium botulinum type A toxin from the alimentary canal, Br. J. Exp. Pathol., 39, 307, 1958.
49. Cicarelli, A. et al., Cultural and physiological characteristics of Clostridium botulinum type G and the susceptibility of certain animals to its toxin, Appl. Environ. Microbiol., 34, 843, 1977.
50. Heckly, R., Hildebrand, G., and Lamanna, C., On the size of the toxic particle passing the intestinal barrier in botulism, J. Exp. Med., 111, 745, 1960.
51. Coulston, F., Albany Medical College Institute of Experimental Pathology and Toxicology Annual Report (2nd), Contract report DA-18-035-AMC-124(A), March 23, 1966.
52. Dack, G. and Gibbard, J., Studies on botulinum toxin in the alimentary tract of hogs, rabbits, guinea pigs and mice, J. Infect. Dis., 39, 171, 1926.
53. Dack, G. and Gibbard, J., Permeability of the small intestine of rabbits and hogs to botulinum toxin, J. Infect. Dis., 39, 181, 1926.
54. Haerem, S., Dack, G., and Dragstedt, L., Acute intestinal obstruction. II. The permeability of obstructed bowel segments of dogs to Clostridium botulinum toxin, Surgery, 3, 339, 1938.
55. Dack, G. and Hoskins, D., Absorption of botulinum toxin from the colon of Macaca mulatta, J. Infect. Dis., 71, 261, 1942.
56. Coleman, I., Studies on the oral toxicity of Clostridium botulinum toxin, type A, Can. J. Biochem. Physiol., 32, 27, 1954.
57. Dong, M. et al., Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells, J. Cell. Biol., 162, 1293, 2003.
58. Sellin, L. et al., Comparison of the effects of Botulinum neurotoxin types A and E at the rat neuromuscular junction, Medical Biology, 61, 120, 1983.
59. Billante, C. et al., Comparison of neuromuscular blockade and recovery with botulinum toxins A and F, Muscle Nerve, 26, 395, 2002.
60. May, A and Whaler, B., The absorption of clostridium botulinum type A toxin from the alimentary canal, Br. J. Exp. Pathol., 39, 307, 1958.
61. Kauffman, J. et al., Comparison of the action of types A and F botulinum toxin at the rat neuromuscular junction, Toxicol. Appl. Pharmacol., 79, 211, 1985.
62. Biskup, R., Snodgrass, H., and Vocci, F., The constancy of the mouse unit in the bioassay of type A botulinum toxin, Edgewood Arsenal Technical Report EATR 4260, 1969.
63. Dolman, C. and Murakami, L., Clostridium botulinum type F with recent observations on other types, J. Infect. Dis., 109, 107, 1961.
64. Iida, H. et al., Studies on the serum therapy of type E botulism: absorption of toxin from the gastrointestinal tract, Jpn. J. Med. Sci. Biol., 23, 282, 1970.
65. Matveev, K., Effect of sublethal doses of botulinal toxin on the organism following multiple administrations, Zhurnal Mikrobiologii, 30, 71, 1959.
66. Rand, M. and Whaler, B., Impairment of sympathetic transmission by botulinum toxin, Nature, 206, 588, 1965.
67. Lamanna, C. and Meyers, C., Influence of ingested foods on the oral toxicity in mice of crystalline botulinal type A toxin, J. Bacteriol., 79, 406, 1959.
68. Herrero, B. et al., Experimental botulism in monkeys - a clinical pathological study, Exp. Mol. Pathol. 6, 84, 1967.
69. Lewis, J., Smith, G., and White, V., An outbreak of botulism in captive hamadryas baboons, Vet. Rec., 126, 216, 1990.
70. Petit, T., Seasonal outbreaks of botulism in captive South American monkeys, Vet. Rec., 128, 311, 1991.
71. Mahmut, N. et al., Characterization of monoclonal antibodies against haemagglutinin associated with Clostridium botulinum type C neurotoxin, J. Med. Microbiol., 51, 286, 2002.
72. Mahmut, N. et al., Mucosal immunisation with Clostridium botulinum type C 16S toxoid and its non-toxic component, J. Med. Microbiol., 51, 813, 2002.
73. Oguma, K. et al., Infant botulism due to Clostridium botulinum type C toxin, Lancet, 336, 1449, 1990.
74. Coffield, J. et al., In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches, J. Pharmacol. Exp. Therap., 280, 1489, 1997.
75. Purkiss, J. et al., Clostridium botulinum neurotoxins act with a wide range of potencies on SH-SY5Y human neuroblastoma cells, Neurotoxicol., 22, 447, 2001.
76. Eleopra, R. et al., Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in human, Neurosci. Lett., 224, 91, 1997.
77. Maksymowych, A. et al., Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockage, Infection and Immunity, 67, 4708, 1999.
78. Chen, F., Kuziemko, G., and Stevens, R., Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species, Infection and Immunity, 66, 2420, 1998.
79. Fujinaga, Y. et al., Identification and characterization of functional subunits of Clostridium botulinum type A progenitor toxin involved in binding to intestinal microvilli and erythrocytes, FEBS Lett., 467, 179, 2000.
80. Sakaguchi, G. et al., Molecular structures and biological activities of Clostridium botulinum toxins, Jpn. J. Med. Sci. Biol., 27, 95, 1974.
81. Mills, D. and Sugiyama, H., Comparative potencies of botulinum toxin for infant and adult mice, Curr. Microbiol., 6, 239, 1981.
82. Miyazaki, S. and Sakaguchi, G., Pathogenesis of chicken botulism, Jpn. J. Med. Sci. Biol., 32, 129, 1979.
83. Ono, T., Karashimada, T., and Iida, H., Studies on the serum therapy of type E botulism (Part III), Jpn. J. Med. Sci. Biol., 23, 177, 1970.
84. Park, J. and Simpson, L., Inhalational poisoning by botulinum toxin and inhalation vaccination with its heavy-chain component, Infection Immunity, 71, 1147, 2003.
85. Palm, P., McNerney, J., and Hatch, T., Respiratory dust retention in small animals, Amer. Med. Assoc. Arch. Indust. Health, 13, 355, 1956.
86. Schlesinger, R., Deposition and clearance of inhaled particles, in Concepts in Inhalation Toxicology, Second Edition, Chapter 8, McClellan, R. and Henderson, R., Eds., Taylor and Francis Group, Washington, D.C., 1995.
87. Franz, D. et al., Efficacy of prophylactic and therapeutic administration of antitoxin for inhalation botulism, in Botulinum and Tetanus Neurotoxins: neurotransmission and biological aspects, Das Gupta, B., Ed., Plenum Press, New York, 1993.
88. Tamariello, R. et al., Toxicity of Clostridium botulinum toxins in Rhesus monkeys after aerosol exposure, poster presentation abstract, Toxinology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, 1996.
89. Oberst, F. et al., Botulinum antitoxin as a therapeutic agent in monkeys with experimental botulism, Edgewood Report CRDLR 3331, DTIC AD0627996, 1965.
90. Oberst, F. et al., Artificial-respiration studies in monkeys incapacitated by experimental botulism, Edgewood Report CRDLR 3346, DTIC AD0482889, 1965.
91. Warheit, D., Interspecies comparisons of lung responses to inhaled particles and gases, Crit. Rev. Toxicol., 20, 1, 1989.
92. Snipes, M., Long term retention and clearance of particles inhaled by mammalian species, Crit. Rev. Toxicol., 20, 1, 1989.